B. Metzler Seel. Sohn & Co. Ag Insulet Corp Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Insulet Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 9,542 shares of PODD stock, worth $2.71 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,542
Previous 45,471
79.02%
Holding current value
$2.71 Million
Previous $9.18 Million
75.81%
% of portfolio
0.02%
Previous 0.1%
Shares
12 transactions
Others Institutions Holding PODD
# of Institutions
731Shares Held
62.8MCall Options Held
628KPut Options Held
854K-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.41 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.21 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.72 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$829 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$670 Million0.49% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $19.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...